
- World Health Organization. (read)
- European COPD Coalition. Key facts. (read)
- Górecka, D., Gorzelak, K., Sliwiński, P., Tobiasz, M., & Zieliński, J. (1997). Effect of long-term oxygen therapy on survival in patients with chronic obstructive pulmonary disease with moderate hypoxaemia. Thorax, 52(8), 674-679.
- Hardinge, M., Suntharalingam, J., & Wilkinson, T. (2015). Guideline update: The British Thoracic Society Guidelines on home oxygen use in adults. Thorax, thoraxjnl-2015.
- Oba, Y. (2009). Cost-effectiveness of long-term oxygen therapy for chronic obstructive disease. The American journal of managed care, 15(2), 97-104.
- Reisfield, G. M., & Wilson, G. R. (2004). The cost of breathing: an economic analysis of the patient cost of home oxygen therapy. American Journal of Hospice and Palliative Medicine®, 21(5), 348-352.
- Stoller, J. K., Panos, R. J., Krachman, S., Doherty, D. E., & Make, B. (2010). Oxygen therapy for patients with COPD: current evidence and the long-term oxygen treatment trial. CHEST Journal, 138(1), 179-187.
- Young, R. P., Hopkins, R. J., Christmas, T., Black, P. N., Metcalf, P., & Gamble, G. D. (2009). COPD prevalence is increased in lung cancer, independent of age, sex and smoking history. European Respiratory Journal, 34(2), 380-386.